Durvalumab After Chemoradiotherapy Extends Survival in Unresectable Stage III NSCLC, Real‑World Study Reveals Edited by Vineeta Teotia Medscape UK October 20, 2025

https://www.medscape.com/viewarticle/durvalumab-after-chemoradiotherapy-extends-survival-2025a1000s0f